Adare Pharma Solutions
Oct. 20, 2022
Taste masking, combined with swallowability and palatability, are integral considerations for oral drug formulations; ensuring both as part of a drug product’s final formulation can serve to increase patient acceptability and adherence to the therapy, which in turn can bolster regulatory acceptance and commercial potential.
In a recent webinar, the first in a four-part series on taste masking, Adare Pharma Solutions and International Flavors and Fragrances (IFF) Inc. offered critical insights into strategies and techniques for optimizing taste masking during the formulation process. Dr. Luigi Boltri Sr., Director of Pharmaceutical Sciences, Business Support & New Technologies at Adare, and Dr. Nasrin Mahmoudi, Technical Manager at IFF, both spoke to some of the key considerations that apply to taste masking, as well as the potential outcomes of its successful inclusion in a patient-centric drug’s formulation – optimized drug performance, improved patient adherence, and better patient outcomes.